The partnership will use Debiopharm's AbYlink conjugation tech in combination with Alkyon’s modular antibody platform.

MARTIGNY, Switzerland & LAUSANNE, Switzerland & SAN DIEGO, June 12, 2025--Debiopharm ( a privately-owned Swiss ...

Recent innovations across the multiple ADC components, such as enhanced antibody-targeting to the tumors, better linker ...

This article explores the current landscape and future potential of cell therapies, including CAR T-cell and stem cell-based ...

The research program will combine Debiopharm’s AbYlink conjugation technology with Alkyon’s modular antibody platform and ...

A study in Chemistry A European Journal reveals that reduced MUC1 antigen density on gold nanoparticles still elicits potent ...

Pharmaceutical Technology serves as the connection to bio manufacturing and development, featuring regulatory updates and ...

Taking inspiration from the CAR T-cell technology used to provide personalized cancer treatments, researchers have conducted ...

India's active COVID case tally crossed the 6,000 mark, with 769 added in the last 48 hours, according to the Union health ...

An autoantibody associated with systemic lupus erythematosus may help improve the performance of immune checkpoint inhibitor ...

Nanoplasmonic biosensors are revolutionizing virus detection, drug screening, and immune profiling, enhancing virology research with exceptional sensitivity.